返回
Digital spatial profiling for pathologists
DOI:10.1007/s00428-024-03955-w.png)
摘要
En 中文
The advent of omics technologies for high-depth tumor profiling has provided new information regarding cancer heterogeneity. However, a bulk omics profile can only partially reproduce tumor complexity, and it does not meet the preferences of pathologists used to perform an in situ assessment of marker expression, for instance, with immunohistochemistry. The NanoString GeoMx (R) Digital Spatial Profiler (DSP) is a platform for morphology-guided multiplex profiling of tissue slides, which allows the digital quantification of target analytes in different neoplastic settings. To illustrate the feasibility and opportunities offered by DSP from a pathologist's perspective, we applied DSP in three different representative neoplastic settings: breast carcinoma, thyroid anaplastic carcinoma, and biphasic mesothelioma. Because of the perfect overlap between the hematoxylin-eosin-stained slide and the GeoMx areas of interest, in breast carcinoma, two different antibodies allowed the distinction of the tumor cells from the surrounding tumor microenvironment. In biphasic mesothelioma, we could distinguish the epithelioid from the sarcomatoid neoplastic component, and in the thyroid, we easily separated the anaplastic areas from the well-differentiated carcinoma. DSP is a promising tool that combines traditional histological evaluation, allowing spatial assessment of a tumor and its surroundings, and innovative in situ digital profiling. Pathologists should not miss the opportunity to combine morphological and genomic analyses and be at the forefront of investigating the progression of dysplasia/neoplasia, low-grade or high-grade, epithelial/mesenchymal, and, more in general, overcoming the concept of in situ vs. bulk genomic methods.
Keyword:
Digital spatial profiling
Surgical pathology
Tissue slides
Hematoxylin-eosin
期刊
IF:
3.1
论文数:
5.4K
被引数:
7.9K
机构
引用论文
Spatial Profiling Identifies Prognostic Features of Response to Adjuvant Therapy in Triple Negative Breast Cancer (TNBC)空间分析确定三阴性乳腺癌 (TNBC) 对辅助治疗反应的预后特征
High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling
CLINICAL CANCER RESEARCH
IF10.2
Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis
SCIENTIFIC REPORTS
IF3.9
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling通过数字空间基因表达谱确定的转移性前列腺癌的肿瘤间和肿瘤内异质性
NATURE COMMUNICATIONS
IF15.7
The histopathologist is essential in molecular pathology quality assurance for solid tumours COMMENT
VIRCHOWS ARCHIV
IF3.1
Short Communication:HIV Type 1 Phenotype, Tropism, and Sequence Patterns: Association and Preference
Advances in tissue-based imaging: impact on oncology research and clinical practice基于组织的成像进展: 对肿瘤学研究和临床实践的影响

